Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported data

被引:5
作者
Bakhriansyah, Mohammad [1 ,2 ]
Souverein, Patrick C. [1 ]
de Boer, Anthonius [1 ]
Klungel, Olaf H. [1 ]
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[2] Lambung Mangkurat Univ, Sch Med, Dept Pharmacol, Banjarmasin, Indonesia
关键词
acute myocardial infarction; conventional NSAIDs; patient's reports; pharmacoepidemiology; pharmacy records; selective COX-2 inhibitors; Utrecht cardiovascular pharmacogenetics study; CARDIOVASCULAR EVENTS; HEART-FAILURE; NSAID USE; POPULATION; CELECOXIB; INFORMATION; MORTALITY; VALIDITY; REGISTRY; DISEASE;
D O I
10.1111/jcpt.12836
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objective Important risk factors and over-the-counter (OTC) dispensing of non-steroidal anti-inflammatory drugs (NSAIDs) are often not routinely recorded in electronic health records. This study aimed to assess the impact of patient's reports on these factors on the risk of acute myocardial infarction (AMI) for NSAID use. Methods A nested case-control study was conducted among adults in the Utrecht Cardiovascular Pharmacogenetics study. Cases were patients with a first diagnosis of AMI as a hospital discharge diagnosis and controls were those without AMI. NSAID exposure was either current use of selective COX-2 inhibitors or conventional NSAIDs. Information was collected from The Dutch PHARMO Database Network (pharmacy records of drug dispensing linked to hospitalization records) and the patient's questionnaire (lifestyle factors, body mass index and history of cardiovascular diseases). Unconditional logistic regression analysis was used to calculate odds ratios (ORs) and to control for confounding factors. Results We identified 970 AMI cases and 2974 controls. Among cases, 11 (1.1%) and 185 (19.1%) were exposed to selective COX-2 inhibitors and conventional NSAIDs, respectively. Compared to non-use, none of these drug classes were associated with an increased risk of AMI (adjusted OR 1.07, 95% CI: 0.52-2.18 and 0.93, 95% CI: 0.77-1.12, respectively). Additional adjustment for potential confounders from patient's reports did not change the risk estimates (adjusted OR 1.08, 95% CI: 0.53-2.22 and 0.89, 95% CI: 0.73-1.09, respectively). What is new and conclusion Additional confounding control for variables from self-reported data or considering self-reported OTC NSAID use did not change the risk estimates for the association between NSAIDs and AMI.
引用
收藏
页码:623 / 631
页数:9
相关论文
共 29 条
[1]   Use of first- and second-generation cyclooxygenase-2 selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction [J].
Andersohn, F ;
Suissa, S ;
Garbe, E .
CIRCULATION, 2006, 113 (16) :1950-1957
[2]   Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data [J].
Bally, Michele ;
Dendukuri, Nandini ;
Rich, Benjamin ;
Nadeau, Lyne ;
Helin-Salmivaara, Arja ;
Garbe, Edeltraut ;
Brophy, James M. .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
[3]   Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis [J].
Caldwell, B ;
Aldington, S ;
Weatherall, M ;
Shirtcliffe, P ;
Beasley, R .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2006, 99 (03) :132-140
[4]   Alcohol Consumption and Mortality in Patients With Cardiovascular Disease A Meta-Analysis [J].
Costanzo, Simona ;
Di Castelnuovo, Augusto ;
Donati, Maria Benedetta ;
Iacoviello, Licia ;
de Gaetano, Giovanni .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (13) :1339-1347
[5]   Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study [J].
de Peuter, Olav R. ;
Lip, Gregory Y. H. ;
Souverein, Patrick C. ;
Klungel, Olaf H. ;
de Boer, Anthonius ;
Bueller, Harry R. ;
Kamphuisen, Pieter W. .
EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (05) :489-495
[6]   Exploring Concordance of Patient-Reported Information on PatientsLikeMe and Medical Claims Data at the Patient Level [J].
Eichler, Gabriel S. ;
Cochin, Elisenda ;
Han, Jian ;
Hu, Sylvia ;
Vaughan, Timothy E. ;
Wicks, Paul ;
Barr, Charles ;
Devenport, Jenny .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2016, 18 (05)
[7]   Validity of Self-Reported Tobacco Smoke Exposure among Non-Smoking Adult Public Housing Residents [J].
Fang, Shona C. ;
Chen, Shan ;
Trachtenberg, Felicia ;
Rokicki, Slawa ;
Adamkiewicz, Gary ;
Levy, Douglas E. .
PLOS ONE, 2016, 11 (05)
[8]   Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals [J].
Fosbol, Emil Loldrup ;
Folke, Fredrik ;
Jacobsen, Soren ;
Rasmussen, Jeppe N. ;
Sorensen, Rikke ;
Schramm, Tina Ken ;
Andersen, Soren S. ;
Rasmussen, Soren ;
Poulsen, Henrik Enghusen ;
Kober, Lars ;
Torp-Pedersen, Christian ;
Gislason, Gunnar H. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (04) :395-405
[9]   Validity of Self-Reported Drug Use Information Among Pregnant Women [J].
Garg, Mahek ;
Garrison, Laura ;
Leeman, Lawrence ;
Hamidovic, Ajna ;
Borrego, Matthew ;
Rayburn, William F. ;
Bakhireva, Ludmila .
MATERNAL AND CHILD HEALTH JOURNAL, 2016, 20 (01) :41-47
[10]   Unmeasured confounding in pharmacoepidemiology [J].
Groenwold, Rolf H. H. ;
de Groot, Mark C. H. ;
Ramamoorthy, Dhivya ;
Souverein, Patrick C. ;
Klungel, Olaf H. .
ANNALS OF EPIDEMIOLOGY, 2016, 26 (01) :85-86